Evaluation of the effect of eltrombopag therapy on the platelet collagen receptor glycoprotein VI (GPVI) expression and soluble GPVI levels in young patients with immune thrombocytopenia

BACKGROUND: Platelet glycoprotein VI (GPVI) receptor is essential for platelet adhesion and aggregation. Eltrombopag is as an effective treatment for chronic immune thrombocytopenia (ITP); yet, its effect on platelet function is not fully characterized. AIM: This prospective study investigated the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Tantawy, Azza Abdel Gawad, Elsherif, Nayera Hazaa Khalil, Ebeid, Fatma Soliman, El-Gamal, Rasha Abd El-Rahman, Ismail, Eman Abdel Rahman, Kenny, Mahmoud A., morcos, Michael Botros Elkes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011314/
https://www.ncbi.nlm.nih.gov/pubmed/36479670
http://dx.doi.org/10.1007/s11239-022-02734-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011314/
https://www.ncbi.nlm.nih.gov/pubmed/36479670
http://dx.doi.org/10.1007/s11239-022-02734-1

Ejemplares similares